Project
Start
November 2019

I-MOVE: a network to measure vaccine effectiveness in Europe

I-MOVE stands for voor 'Influenza – Monitoring Vaccine Effectiveness in Europe'. Since 2007, the international I-MOVE network measures influenza vaccine effectiveness during the influenza season. It makes its data available to health authorities as soon as possible after the start of the seasonal epidemic or pandemic.

Aim
This point is crucial to deploy an appropriate response, and in particular, to:
- decide on recommendations to be communicated for vaccine use
- yarget complementary or alternative measures (e.g. antivirals) for population subgroups in which the vaccine is less effective
- accurately estimate the impact of current vaccination strategies on the disease so as to support vaccination campaigns
- initiate further research on seasonal and pandemic vaccines (to improve composition, decide on the use of adjuvants or the need for booster doses),
- anticipate when the vaccine will be out of stock (especially during a pandemic)

Method
In the Netherlands, data is being collected as part of the national influenza surveillance system by sentinel general practitioners participating in Nivel Primary Care Database in collaboration with RIVM.

Funding
The I-MOVE network was initiated with funding from Member States and the European Centre for Disease Prevention and Control (ECDC) and is being coordinated by Epiconcept (Paris). The last grant was reveived for the period 2019-2020.
Funding
European Centre for Disease Prevention and Control (ECDC)
In this project we work together with
EpiConcept (Parijs)